US Patent Issued to Egetis Therapeutics on May 20 for "Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions" (Swedish, Danish Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,516, issued on May 20, was assigned to Egetis Therapeutics AB (Stockholm).

"Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions" was invented by Jacques Nasstrom (Bromma, Sweden), Sven Jacobsson (Stockholm), Dennis Henriksen (Allerod, Denmark) and James Van Alstine (Stockholm).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating and/or protecting against acute liver failure and other hepatotoxicities in an individual employ a combination of a first active agent comprising N-acetylcysteine and a second active agent comprising a manganese complex selected from the group...